Breast - Refresher 2020
This educational activity will focus on the radiation therapy treatment scenarios commonly faced in practice; i.e., breast radiation for early stage disease undergoing breast conservation and regional nodal irradiation for node positive breast cancer. Breast radiation following lumpectomy for ductal carcinoma in situ and early invasive breast cancer including whole breast irradiation; partial breast irradiation and observation, as well as the clinical trial data supporting treatment effectiveness, will be reviewed. This educational activity will also focus on the evidence, indications and methodology for regional nodal irradiation post mastectomy or lumpectomy in breast cancer patients with 1-3 axillary nodal metastasis in the setting of adjuvant systemic therapy. Regional nodal irradiation in the post neoadjuvant systemic therapy setting will be reviewed as well.
This activity is available from March 30, 2020, through 11:59 p.m. Eastern time on March 29, 2023.
This activity was originally recorded during ASTRO’s 2020 Annual Refresher Live Interactive Virtual Conference, March 20-22, 2020.
The activity is designed to meet the interests of radiation oncologists, physicists, nurses, radiation therapists, radiation dosimetrists and radiation oncology residents.
- Identify current acceptable radiation methods and suitable patient populations for breast conserving treatment in early stage invasive and non-invasive breast cancer.
- Describe the rationale and indications for regional nodal irradiation post mastectomy and lumpectomy for node positive breast cancer in the setting of adjuvant and neoadjuvant systemic therapy.
- Recognize radiation methods that maximize the therapeutic ratio by minimizing toxicity from breast conserving therapy in early stage disease and regional nodal irradiation in node positive disease.
Julia White, MD, FASTRO is employed by Ohio State University and has no financial relationships with a commercial interest.
The person(s) above served as the developer(s) of this activity. Additionally, the Education and CME/MOC Committees had control over the content of this activity.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 1.50 Certificate of AttendanceThis activity was designated for 1.50 AMA PRA Category 1 Credit™.
- 1.50 SA-CME
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.
The American Society for Radiation Oncology (ASTRO) designates this Enduring material for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.50 self-assessment credits.
• No refunds, extensions or substitutions will be made for those registrants who, for any reason, were unable to attend or were tardy for the session.
• No credits will be granted and no refunds, exchanges or transfers will be given to those who do not pass.
• ASTRO staff cannot make modifications to your submitted materials.
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.